HOME > News Releases

News Releases

2016.01.27
Finances
PDF/549KB
Supplementary Financial Data for the Third Quarter of the Year Ending March 31, 2016
2016.01.27
Finances
PDF/330KB
Summary of Consolidated Financial Results for the Third Quarter of the Year Ending March 31, 2016 [Japanese GAAP] (Unaudited)
2016.01.25
R&D
PDF/57KB
Boston Biomedical’s Investigational Cancer Stem Cell Pathway Inhibitor, Napabucasin (BBI608), Featured at the ASCO 2016 Gastrointestinal Cancers Symposium
2016.01.25
R&D
PDF/229KB
Sunovion Announces Results from a Study Evaluating the Abuse Potential of Investigational Drug Dasotraline
2015.12.01
Corporate
PDF/101KB
Sumitomo Dainippon Pharma announces Organizational Realignment and Changes in Executive Officers and Other Key Positions
2015.11.10
Products
PDF/187KB
Received the Award for the First Time with the Pen-Style Medical Injector. A Unique Injector, “Ateos” for “Trulicity” Type 2 Diabetes Treatment Received “Good Design Gold Award.”

Page Top